Literature DB >> 16441377

Disruption of ste23 gene affects composition profile and bioactivity of exopolysaccharide produced by Streptomyces sp. 139.

T Zhang1, L Wang, G Xu, Y Chen, Y Zhang, Y Li.   

Abstract

AIMS: To study the function of the gene ste23 involved in the biosynthesis of Ebosin. METHODS AND
RESULTS: In search of databases, the deduced product of the gene ste23 showed high homology to dTDP-4-dehydrorhamnose 3,5-epimerases. ste23 was replaced by a kanamycin resistance gene through double crossover. Compared with Ebosin, an exopolysaccharide (EPS) produced by wild-type Streptomyces sp. 139, the EPS produced by the ste23 mutant (designated EPS1) had a remarkably different monosaccharide composition and significantly diminished rhamnose content, though the molecular mass of EPS1 was similar to that of Ebosin. In addition, EPS1 lost the interleukin 1 (IL-1) antagonist activity in vitro.
CONCLUSIONS: ste23 may be involved in the Ebosin biosynthesis in S. sp. 139. and its bioactivity. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first genetic work investigating functions of genes involved in EPS production in streptomyces by gene replacement of the pathway genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441377     DOI: 10.1111/j.1472-765X.2005.01810.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  2 in total

1.  Identification of a methyltransferase encoded by gene stel16 and its function in Ebosin biosynthesis of Streptomyces sp. 139.

Authors:  Hong-Guan Xie; Yong-Gang Bao; Li-ping Bai; Jun-Jie Shan; Rong Jiang; Yang Zhang; Lian-Hong Guo; Ren Zhang; Yuan Li
Journal:  J Microbiol       Date:  2009-05-02       Impact factor: 3.422

2.  A DasA family sugar binding protein Ste2 links nutrient and oxidative stress to exopolysaccharides production in Streptomyces sp. 139.

Authors:  Mengxin Geng; Limei Ai; Ming Ma; Panpan Li; Lianhong Guo; Guangzhi Shan; Liping Bai
Journal:  BMC Microbiol       Date:  2022-03-08       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.